期刊文献+

胆固醇-聚乙烯亚胺共聚物的制备及其表征

Synthesis and characterization of polyethyleneimine-cholesterol copolymer
下载PDF
导出
摘要 目的用胆固醇(Chol)对聚乙烯亚胺(PEI)进行改性,制备适用于基因转染的非病毒类载体。方法用胆固醇甲酰氯(Chol-Cl)连接聚乙烯亚胺的氨基形成PEI-Chol脂质共聚物,分别用IR、1H-NMR、凝胶色谱法、DSC对聚合物进行表征。结果在IR图谱上可见1 800 cm-1峰为Chol-Cl的羰基特征峰,形成PEI-Chol后,羰基特征峰迁移至1 700 cm-1,表明聚乙烯亚胺与胆固醇成功连接;根据1H-NMR谱图计算PEI的胺基接枝率、组成及相对分子质量,达到试验预期效果,表明反应可控;凝胶色谱法测定发现聚合物为单峰,表明连接成功,且聚合物相对分子质量的测定值与1H-NMR估算值比较接近;DSC图谱显示PEI连接胆固醇,Chol-Cl的吸收峰消失,熔融峰(Tm)升高变钝,表明PEI-Chol刚性增强。结论成功合成了PEI-Chol脂质共聚物。 Objective Polyethyleneimine(PEI) was modified with cholesterol(Chol) in order to improve its physical properties for nonviral gene delivery.Method PEI-Chol lipopolymer was synthesized by linking cholesteryl chloroformate(Chol-cl) to the amino groups of branched poly(ethylenimine)(PEI).The copolymer was characterized by IR,1H-NMR,gel permeation chromatography(GPC) and DSC analysis.Result IR spectrum showed the special carbonyl peak(1 800 cm^-1) of Chol-Cl changed into the carbonyl peak(1 700 cm^-1) of PEI-Chol which meant the bond connection of PEI and Chol.The results of 1H-NMR analysis indicated the polymerization was a controlled reaction in which the composition and molecular weight of the copolymer could be controlled through adjusting ratio rates.The GPC of the polymer as a single peak indicated that the connection between PEI and Chol-Cl was successful,and the polymer molecular weight of PEI-Chol were relatively close to the the estimated results with the 1H-NMR.DSC plots showed the absorption peak of Chol-Cl disappeared and the the melting peaks(Tm) increased,which meant the rigidity of PEI enhanced after connection of cholesterol.Conclusions The results indicated the PEI-Chol block copolyers were synthesized successfully.
出处 《广东药学院学报》 CAS 2012年第3期231-235,共5页 Academic Journal of Guangdong College of Pharmacy
基金 广东省科技计划项目(01037960128052026) 广东省医学科学基金项目(A2011140)
关键词 聚乙烯亚胺 胆固醇 共聚物 polyethyleneimine cholesterol copolymer
  • 相关文献

参考文献9

  • 1KAWAKAMI S, HIGUCHI Y, HASHIDA M. Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide[ J ]. J Pharm Sci, 2008,97 ( 2 ) : 726 - 728.
  • 2ETHLINN VB, VAN G, WIM E, et al. Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy [ J ]. Pharm Res ,2006 ,23 ( 6 ) : 1053 - 1054.
  • 3BOUSSIF O, LEZOUALC "H F, ZANTA MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo polyethylenimine [ J ]. Proc Natl Acad Sci USA,1995,92(6) :7297 -7299.
  • 4HAN S, MAHATO R I, KIM S W. Water-soluble lipopolymer for gene delivery [ J ]. Bioconjug Chem, 2001, 12(3) :337 -339.
  • 5LEE M, RENTZ J, HANS O, et al. Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium [ J ]. Gene Ther,2003,10 (7) :585 - 587.
  • 6WON J K, CHIEN W C, MINHYUNG L, et al. Efficient siRNA delivery using water soluble lipopolymer for anti- angiogenic gene therapy [ J]. J Control Release,2007,118 (3) :357 - 359.
  • 7VINOGRADOV S V, BATRAKOVA E V, KABANOV A V. Nanogels for oligonucleotide delivery to the brain [ J ]. Bioconjug Chem,2004,15( 1 ) :50 -53.
  • 8KIRCHEIS R, WIGHTMAN L, WAGNER E. Design and gene delivery activity of modified polyethylenimines [ J ]. Adv Drug Deliv Rev ,2001,53 ( 3 ) :341 - 343.
  • 9KICHLER A. Gene transfer with modified polyethylenimines [J]. J C, ene Med,2004(6) :S3.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部